Until those studies are complete and the FDA reviews the data, it remains an experimental medication
WHY THIS PROGRAM GLP-1 Medications Are Just the Start GLP-1 receptor agonists might be strong tools for weight loss but without proper monitoring and exercise programming, users risk losing critical lean muscle mass, missing key body composition changes, and leaving results on the table
None of them replaces a functional metabolic foundation
The problem has only become more complex with the skyrocketing use of glucagon-like peptide 1 class (GLP-1) drugs, such as Ozempic and Wegovy
This is also where self-compassion matters
Heartburn-related side effects also occurred: Dyspepsia: 9% GERD: 5% Belching: 7% So, why did heartburn-related side effects, such as dyspepsia and GERD, show up more often in patients taking Wegovy vs